Kim Bohye, Weerasinghe-Mudiyanselage Poornima D E, Ang Mary Jasmin, Lee Jeongmin, Kang Sohi, Kim Jong-Choon, Kim Sung-Ho, Kim Joong-Sun, Jung Chaeyong, Shin Taekyun, Moon Changjong
Department of Veterinary Anatomy and Animal Behavior, College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University, Gwangju, Korea.
Department of Anatomy, Chonnam National University Medical School, Gwangju, Korea.
Int Neurourol J. 2022 Nov;26(Suppl 2):S94-105. doi: 10.5213/inj.2244252.126. Epub 2022 Nov 30.
Parkinson disease (PD) is a progressive neurodegenerative disorder in which dopaminergic (DAergic) systems are destroyed (particularly in the nigrostriatal system), causing both motor and nonmotor symptoms. Hippocampal neuroplasticity is altered in PD animal models, resulting in nonmotor dysfunctions. However, little is known about the precise mechanism underlying the hippocampal dysfunctions in PD.
Striatal 6-hydroxydopamine (6-OHDA) infusions were performed unilaterally in adult Sprague Dawley rats. Both motor and nonmotor symptoms alongside the expression of tyrosine hydroxylase (TH) in the substantia nigra and striatum were confirmed in 6-OHDA-lesioned rats. The neuronal architecture in the hippocampus was analyzed by Golgi staining.
During the 7-8 weeks after infusion, the 6-OHDA-lesioned rats exhibited motor and nonmotor dysfunctions (especially anxiety/depression-like behaviors). Rats with unilateral 6-OHDA infusion displayed reduced TH+ immunoreactivity in the ipsilateral nigrostriatal pathway of the brain. Golgi staining revealed that striatal 6-OHDA infusion significantly decreased the dendritic complexity (i.e., number of crossing dendrites, total dendritic length, and branch points) in the ipsilateral hippocampal conus ammonis 1 (CA1) apical/basal and dentate gyrus (DG) subregions. Additionally, the dendritic spine density and morphology were significantly altered in the CA1 apical/basal and DG subregions following striatal 6-OHDA infusion. However, alteration of microglial and astrocytic distributions did not occur in the hippocampus following striatal 6-OHDA infusion.
The present study provides anatomical evidence that the structural plasticity in the hippocampus is altered in the late phase following striatal 6-OHDA infusion in rats, possibly as a result of the prolonged suppression of the DAergic system, and independent of neuroinflammation.
帕金森病(PD)是一种进行性神经退行性疾病,其中多巴胺能(DAergic)系统被破坏(特别是在黑质纹状体系统中),导致运动和非运动症状。在PD动物模型中,海马神经可塑性发生改变,导致非运动功能障碍。然而,关于PD中海马功能障碍的确切机制知之甚少。
对成年Sprague Dawley大鼠单侧进行纹状体内6-羟基多巴胺(6-OHDA)注射。在6-OHDA损伤的大鼠中确认了运动和非运动症状以及黑质和纹状体中酪氨酸羟化酶(TH)的表达。通过高尔基染色分析海马中的神经元结构。
在注射后7-8周内,6-OHDA损伤的大鼠表现出运动和非运动功能障碍(特别是焦虑/抑郁样行为)。单侧注射6-OHDA的大鼠在大脑同侧黑质纹状体通路中显示TH +免疫反应性降低。高尔基染色显示,纹状体内注射6-OHDA显著降低了同侧海马锥体细胞层1(CA1)顶/基部和齿状回(DG)亚区域的树突复杂性(即交叉树突数量、总树突长度和分支点)。此外,纹状体内注射6-OHDA后,CA1顶/基部和DG亚区域的树突棘密度和形态发生了显著改变。然而,纹状体内注射6-OHDA后海马中微胶质细胞和星形胶质细胞分布未发生改变。
本研究提供了解剖学证据,表明大鼠纹状体内注射6-OHDA后晚期海马的结构可塑性发生改变,这可能是由于多巴胺能系统长期受抑制所致,且与神经炎症无关。